Position in PRAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$285,948,152
+$17,405,689 QoQ
Shares Held
854,112
+2.5% QoQ
Ownership
3.06%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#14
of 308 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. PRAX ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in PRAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,948,152 | 854,112 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $268,542,463 | 833,491 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $262,285,882 | 889,889 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $34,105,235 | 643,495 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $51,567,552 | 1,226,339 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $45,961,642 | 1,213,669 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $89,544,958 | 1,163,526 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $4,631,967 | 80,500 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $7,623,430 | 184,319 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,110,296 | 100,136 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $377,266 | 16,933 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $496,263 | 290,213 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $279,441 | 242,996 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $670,279 | 828,534 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $433,292 | 182,057 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $623,959 | 274,873 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,291,693 | 527,223 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $736,118 | 72,098 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $399,728 | 20,291 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $267,806 | 14,484 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,828,308 | 100,017 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $144,438 | 4,409 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $788,491 | 14,331 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||